Wang Junyuan Jerry — SEC Form 4 filings

SEC reporting owner CIK 2017749. 3 Form 4 filings on record with FilingPulse; latest filed 2024-11-13.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-04-11 to 2024-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nuvation Bio Inc. (NUVB)CEO, ANHEART THERAPEUTICS LTD., Director31 leg · 56,361 sh · $162,88312

Form 4 filings — Wang Junyuan Jerry

FiledFormIssuerReported transactionsSource
2024-11-134Nuvation Bio Inc. (NUVB)Sale (S): 56,361 @ $2.89EDGAR
2024-09-054Nuvation Bio Inc. (NUVB)Conversion (C): 2,543,600 · Conversion (C): 1,695,700 · Grant/award (A): 25,436 (derivative) · Grant/award (A): 16,957 (derivative) · Grant/award (A): 86,471 (derivative) · Grant/award (A): 57,647 (derivative) · +2 moreEDGAR
2024-04-114Nuvation Bio Inc. (NUVB)Grant/award (A): 1,378,989 @ $0 · Grant/award (A): 550,758 @ $0 · Grant/award (A): 486,669 (derivative) @ $0 · Grant/award (A): 388,299 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2017749 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →